CFG
GOSS icon

Citizens Financial Group’s Gossamer Bio GOSS Stock Holding History

Citizens Financial Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22K Buy
+13,478
New +$3.76K ﹤0.01% 1047

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Citizens Financial Group's GOSS Position: Q2 2026 in Review

Citizens Financial Group opened a new position in Gossamer Bio (GOSS) in Q2 2026: 13,478 shares worth $2.22K. The stake represents ﹤0.01% of the portfolio and ranks #1047 among its holdings.

170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Citizens Financial Group held 13,478 shares of Gossamer Bio worth $2.22K as of Q2 2026.
  • Gossamer Bio was a new Citizens Financial Group position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Citizens Financial Group's portfolio in Q2 2026, its #1047 holding.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.